Evidence map›Paper›PMID 40416496›Full record

ArticleSovremennye tekhnologii v meditsine2025

Criteria for Vaginal Atrophic Changes in Genitourinary Syndrome of Menopause Using Optical Coherence Tomography.

L Z Sirotina, A L Potapov, M M Loginova, L V Shkalova, A D Varnavskaya, K V Kazakova, A A Chaikin, D A Bolshakova, M A Sirotkina, T M Motovilova and 1 more

Abstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

L Z SirotinaAssistant, Department of Obstetrics and Gynecology; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
A L PotapovLaboratory Technician, Scientific Laboratory of Optical Coherence Tomography, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
M M LoginovaJunior Researcher, Scientific Laboratory of Optical Coherence Tomography, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
L V ShkalovaHead of Anatomic Pathology Department; Privolzhsky District Medical Center of Federal Medico-Biologic Agency of Russia, 2 Nizhnevolzhskaya naberezhnaya St., Nizhny Novgorod, 603005, Russia.
A D Varnavskaya6-year Student, Faculty of General Medicine; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
K V Kazakova6-year Student, Faculty of General Medicine; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
A A Chaikin6-year Student, Faculty of General Medicine; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
D A Bolshakova6-year Student, Faculty of Pediatrics; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
M A SirotkinaDirector, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
T M MotovilovaAssociate Professor, Department of Obstetrics and Gynecology; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.
N D GladkovaProfessor, Head of the Scientific Laboratory of Optical Coherence Tomography, Research Institute of Experimental Oncology and Biomedical Technologies; Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603005, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: The study involved 25 patients with clinical presentation of GUMS and 3 virtually healthy women (mean age - 56.7±1.4 years). On gynecological examination the patients underwent colpo- and vaginoscopy, their vaginal health index being calculated. OCT study was performed in three anatomical points of the upper vagina and the vaginal vestibule (these regions are rich in estrogen receptors and most frequently affected in GUSM). The biopsy was taken from the right point of the vaginal vestibule followed by a histological examination and PAS reaction to reveal glycogen. The epidermal thickness was quantitatively assessed by OCT and histological images. There were determined the signal levels from the epithelium and the connective tissue, the epithelial stromal stratification being performed. Results: Normal vaginal mucosa in OCT images had stratified structure including the epithelium 503 [467; 550] μm thick, with low intensity of OCT signal and the proper mucous plate with a high OCT signal. As a result of the difference in signal levels from the epithelium and the proper mucous plate, the contrast boundary formed between them. The signal level from the epithelium was 54.1 [51.5; 56.3] RU, and that from the connective tissue - 70.7 [65.9; 73.7] RU. The mucosa had folds, which in OCT images looked like a waveform boundary of the epithelium and the submucosa.Based on vaginal health index values and colpo- and vaginoscopy findings, GUSM patients were divided into 2 groups: patients with mild mucosal atrophy and those with severe mucosal atrophy. The first group of patients was observed to have the reduced epithelial thickness of up to 261 [244; 289] μm; the signal from the epithelium increased due to the decrease in glycogen content, and was 61.6 [55.0; 65.5] RU, and the connective tissue signal was 79.5 [77.2; 79.9] RU. Mucosal folds were not visible. Severe atrophy patients had a significant decrease in the epithelial thickness, up to 158 [143; 191] μm; the signal from the epithelium was 69.7 [67.1; 72.4] RU reducing the boundary contrast of the epithelium and the submucosal base (it can be explained by glycogen absence); the signal from the connective tissue was 90.32 [80.90; 101.60] RU. Mucosal folds were not visible. The stratification index showed no changes due to the fact that the signal intensity in vaginal atrophy increases synchronically from both: the epithelium and the proper plate (stroma). The epidermal thickness measured histologically showed a high coherence level with OCT measurements (r=0.93; p<0.0001). Conclusion: The study determined OCT criteria of the age norm for vaginal mucosa changes and atrophy in mild and severe GUSM that will enable to facilitate the personalization of the therapy approaches and optimize the management of such patients.

Indexed as

Female Urogenital DiseasesMenopauseTomography, Optical CoherenceVaginaVaginal DiseasesAtrophyFemaleHumansMiddle AgedSyndromegenitourinary syndrome of menopauseoptical coherence tomographyvaginal atrophy

Identifiers

PMID40416496
PMCPMC12096360

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.